Table 1.
Microbial pathogens in COPD
| Microbe | Role in Exacerbations | Role in Stable Disease |
|---|---|---|
| Bacteria | ||
| H influenzae | 20%–30% of exacerbations | Major pathogen |
| Streptococcus pneumoniae | 10%–15% of exacerbations | Minor role |
| Moraxella catarrhalis | 10%–15% of exacerbations | Minor role |
| Pseudomonas aeruginosa | 5%–10% of exacerbations, prevalent in advanced disease | Likely important in advanced disease |
| Enterobacteriaceae | Isolated in advanced disease, pathogenic significance undefined | Undefined |
| Haemophilus haemolyticus | Isolated frequently, unlikely cause | Unlikely |
| Haemophilus parainfluenzae | Isolated frequently, unlikely cause | Unlikely |
| Staphylococcus aureus | Isolated infrequently, unlikely cause | Unlikely |
| Viruses | ||
| Rhinovirus | 20%–25% of exacerbations | Unlikely |
| Parainfluenza | 5%–10% of exacerbations | Unlikely |
| Influenza | 5%–10% of exacerbations | Unlikely |
| Respiratory syncytial virus | 5%–10% of exacerbations | Controversial |
| Coronavirus | 5%–10% of exacerbations | Unlikely |
| Adenovirus | 3%–5% of exacerbations | Latent infection seen, pathogenic significance undefined |
| Human metapneumovirus | 3%–5% of exacerbations | Unlikely |
| Atypical Bacteria | ||
| Chlamydophila pneumoniae | 3%–5% of exacerbations | Commonly detected, pathogenic significance undefined |
| Mycoplasma pneumoniae | 1%–2% | Unlikely |
| Fungi | ||
| Pneumocystis jiroveci | Undefined | Commonly detected, pathogenic significance undefined |
From Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 2008;359:2356; with permission.